About The Oncology Report

The Oncology Report features comprehensive reports on the latest advances in cancer treatment presented at major oncology meetings with expert commentaries and analysis from renowned thought-leaders. The Oncology Report is designed with an attractive, easy-to-read format organized by tumor site. Each chapter features a topic index and reference to the meetings covered. TOR is sent free of charge to over 14,000 physicians, nurses, pharmacists and administrators.

Our Mission
Oncology Report Digital Network is the online destination and multimedia properties of The Oncology Report, the independent news publication for oncologists. The Oncology Report is the leading source of news and commentary about clinical developments in oncology as well as health care policy and regulations that affect the physician’s practice. Oncology Report Digital Network is owned by the International Medical News Group division of Elsevier.

Editorial Advisory Board

Editor
Howard A. Burris III, M.D.
Chief Medical Officer & Director of Drug Development 
Sarah Cannon Research Institute
Nashville, Tennessee 

Associate Editors

Brain/CNS Tumors
Henry S. Friedman, M.D.
James B. Powell Jr. Professor of Neuro-Oncology
Professor of Pediatrics
Associate Professor of Surgery Medicine
Assistant Professor of Pathology
Deputy Director
Preston Robert Tisch Brain Tumor Center
Duke University
Durham, N.C.

Breast Cancer
William J. Gradishar, M.D.
Betsy Bramsen Professor of Breast Oncology
Director
Maggie Daley Center For Women's Cancer Care
Robert H. Lurie Comprehensive Cancer Center
Northwestern University Feinberg School of Medicine, Northwestern Memorial Hospital,
Chicago, Illinois

Hope S. Rugo, M.D.
Clinical Professor of Medicine
Director, Breast Oncology and Clinical Trials Education
UCSF Helen Diller Family Comprehensive Cancer Center
San Francisco, California

Gastrointestinal Malignancies
Johanna C. Bendell, M.D.
Director, GI Oncology Research
Associate Director, Drug Development Unit
Sarah Cannon Research Institute
Nashville, Tennessee

Stuart M. Lichtman, M.D.
Professor of Medicine, Weill Cornell Medical College
Commack, New York
Attending Physician, Clinical Geriatrics Program, Memorial Sloan-Kettering Cancer Center
New York, New York

Malcolm J. Moore, M.D.
Professor of Medicine and Pharmacology
University of Toronto
Head, Division of Medical Oncology and Hematology, Princess Margaret Hospital/University Health Network and Mt. Sinai Hospital
Director, Drug Development Program, Chief of Medical Services, Princess Margaret Hospital
Toronto, Ontario

Genitourinary Malignancies
Judd W. Moul, M.D.
Professor and Chief, Division of Urologic Surgery
Director, Duke Prostate Center
Duke University
Durham, North Carolina

Walter M. Stadler, M.D.
Fred C. Buffett Professor of Medicine
Surgery Associate Dean for Clinical Research
Director, Genitourinary Program
University of Chicago Medical Center
Chicago, Illinois

With Daniel J. George, M.D.
Associate Professor of Medicine and Surgery
Divisions of Medical Oncology and Urology
Duke University
Durham, North Carolina

With Andrew J. Armstrong, M.D.
Assistant Professor of Medicine and Surgery
Divisions of Medical Oncology and Urology
Duke University
Durham, North Carolina

Gynecologic Malignancies
Maurie Markman, M.D.
Vice President for Medical Oncology Services
National Director of Medical Oncology
Cancer Treatment Centers of America
Eastern Regional Medical Center
Philadelphia, Pennsylvania

Head and Neck Cancer
Marshall R. Posner, M.D.
Director, Head and Neck Medical Oncology
Professor of Medicine
Professor of Gene and Cell Medicine
The Tisch Cancer Institute
Mount Sinai School of Medicine
New York, New York

Hematologic Malignancies: Leukemia, Myelodysplasia, and Transplantation
Steven E. Coutré, M.D.
Associate Professor of Hematology
Director, Hematology Clinic
Stanford University
Stanford, California

Hematologic Malignancies: Lymphoma and Plasma Cell Disorders
Kenneth C. Anderson, M.D.
Kraft Family Professor of Medicine
Harvard Medical School Chief
Division of Hematologic Neoplasia
Director, Jerome Lipper Multiple Myeloma
Center Dana-Farber Cancer Institute
Boston, Massachusetts

Lung Cancer
Roy S. Herbst, M.D., Ph.D.
Chief of Medical Oncology
Associate Director for Translational Research
Yale Cancer Center
New Haven, Conn.

Vincent A. Miller, M.D.
Associate Attending Physician, Thoracic Oncology Service
Memorial Sloan-Kettering Cancer Center
New York, New York

Melanoma
Jeffrey A. Sosman, M.D.
Professor of Medicine
Vanderbilt-Ingram Cancer Center
Melanoma Program Co-leader
Signal Transduction and Cell Proliferation Program
Vanderbilt University, Section of Hematology/Oncology
Nashville, Tennessee

Pediatric Cancers
Gregory H. Reaman, M.D.
Professor of Pediatrics
The George Washington University
Washington, D.C.
Chairman
Children’s Oncology Group
Bethesda, Maryland

Sarcoma
George D. Demetri, M.D.
Director
Center for Sarcoma and Bone Oncology
Dana-Farber Cancer Institute
Associate Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Patient and Survivor Care
Charles L. Loprinzi, M.D.
Director, North Central Cancer Treatment Group (NCCTG) Cancer Control Program
Codirector, Prevention and Control Program for the Mayo Cancer Center
Professor of Oncology, Mayo Medical School
Rochester, Minnesota

Practice Trends
Lee S. Schwartzberg, M.D.
Medical Director
West Clinic President and Chief Medical Officer
Accelerated Community Oncology Research Network (ACORN)
Clinical Professor of Hematology, University of Tennessee Health Science Center
Memphis, Tennessee

Editorial Staff

Alan J. Imhoff, President, IMNG
Mary Jo M. Dales, Editor in Chief, IMNG
Denise Fulton, Executive Editor, IMNG
Kathy Scarbeck, Executive Editor, IMNG
Jane Salodof MacNeil, senior editor for IMNG's oncology/hematogy websites

Senior Editors
Christina Chase
Kathryn DeMott
Jeff Evans
Lori Buckner Farmer
Catherine Hackett
Keith Haglund
Gina L. Henderson
Sally Koch Kubetin
Teresa Lassman
Mark S. Lesney
Renée Matthews
Catherine Cooper Nellist
Amy Pfeiffer
Terry Rudd
Leanne Sullivan
Elizabeth Wood

Associate Editors
Felicia Rosenblatt Black
Therese Borden
Lorinda Bullock
Steve Cimino
Jay C. Cherniak
Virginia Ingram-Wells
Jane Locastro
Carol Nicotera-Ward

Reporters
Alicia Ault (Washington)
Sherry Boschert (San Francisco)
Doug Brunk (San Diego)
Frances Correa (Washington)
Bruce Jancin (Denver)
Diana Mahoney (New England)
Damian McNamara (Miami)
Elizabeth Mechcatie (Washington)
Naseem Miller (Washington)
Mary Ellen Schneider (New York)
Jennie Smith (Germany)
Heidi Splete (Washington)
Michele G. Sullivan (Mid-Atlantic)
Miriam E. Tucker (Washington)
Kerri Wachter (Washington)
Patrice Wendling (Chicago)
Mitchel L. Zoler (Philadelphia)

Contributing Writers
Christine Kilgore
Mary Ann Moon

Operations Team
Jim Chicca, Executive Director of Operations, IMNG
Yvonne Evans Struss, Director, Production/Manufacturing
Judi Sheffer, Production Manager
Maria Aquino, Anthony Draper, Rebecca Slebodnik, Production Specialists
Jon Li, Web Production Engineer
Jennifer Calhoun, Web Production Engineer

Doug Sullivan, Director of Information Technology
Lee J. Unger, Senior Systems Administrator
Peter Ayinde, Systems Administrator/Application Support

Louise A. Koenig, Creative Director
Elizabeth Byrne Lobdell, Design Supervisor
Sarah L. G. Breeden, Yenling Liu, Senior Designers
Lisa M. Marfori, Designer
Catherine Harrell, Photo Editor

Susan D. Hite, Project Manager
Megan Evans, Assignments Manager
Daniela Silva, Accounts Payable Coordinator

Our Advertising and Business Services Teams
Mark E. Altier, Director of Sales, IMNG
Tel: 973-290-8220
E-mail: m.altier@elsevier.com

Phil Soufleris, Sales Manager
Tel: 973-290-8224
E-mail: p.soufleris@elsevier.com

Devin Gregorie, National Account Manager
Tel: 631-424-8900, Ext. 305
d.gregorie@elsevier.com

Robert Zwick, Classified Sales Manager, IMNG
Tel. 973-290-8226
E-mail: r.zwick@elsevier.com

Display Advertising
The Braveheart Group, LLC
120 North Central Avenue
Suite 1 North
Ramsey, NJ 07446
Fax: (201) 529-4007
Peter Murphy: (201) 529 4020
Email: pmurphy@braveheart-group.com
Stuart Williams
s.williams@braveheart-group.com

Advertising Offices
60 Columbia Rd., Bldg. B
Morristown, NJ 07960
Tel: 973-290-8200
Fax: 973-290-8250

Classified Advertising Offices
1120 Jensen Ave.,
Mamaroneck, NY 10543
Tel: 800-381-0569

Dennis Quirk, Business Controller

Joan Friedman, Advertising Services Manager

Patricia H. Ramsey, Credit Supervisor

Barbara Cavallaro, Audience Development Manager
Tel: 973-290-8253
E-mail: b.cavallaro@elsevier.com

Malika Wicks, Sr. Program Manager, Customized Programs

Jennifer Eckert, Manager, Marketing and Research

Lynne Kalish, Manager, Admin./Conventions

Linda Wilson, Editorial Assistant

Address Changes
Fax change of address (with old mailing label) to 973-290-8245 or e-mail change to subs@elsevier.com.

Licensing/Reprints/Eprints:
Nick Iademarco
Sales Manager
Wright's Media
2407 Timberloch Place
Suite B
The Woodlands, Texas 77386
Toll Free: 877-652-5295, ext. 102
Fax: 281-419-5712
Email: niademarco@wrightsmedia.com
www.wrightsmedia.com

Our Business
Oncology Report Digital Network is commercially supported by advertising and sponsorships. Online access to most of our content is free. Most premium content is available free to registered users. The sources of our content are clearly identified. Oncology Report Digital Network strives to provide content that is accurate, objective, and fair. Our news is not influenced in any way by commercial sponsors or content contributors. Oncology Report Digital Network invites strategic alliances and partnerships with others who share its high standards and seek to serve and enhance the oncology community. We also welcome reciprocal linking arrangements with reputable medical professional information and research websites. For more information regarding content integration and partnership opportunities, please contact Alan Imhoff at a.imhoff@elsevier.com.

About Elsevier
Elsevier is a world-leading publisher of scientific, technical, and medical information products and services. Working in partnership with the global science and health communities, Elsevier’s 7000 employees in over 70 offices worldwide publish more than 2000 journals and 1900 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect, MD Consult, Scopus, bibliographic databases, and online reference works.

Elsevier is a global business headquartered in Amsterdam, the Netherlands, and has offices worldwide. Elsevier is part of Reed Elsevier Group plc, a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK, and ENL (New York Stock Exchange).

Last updated October 3, 2011